California Patent of the Month – December 2023

Pensievision is developing innovative three-dimensional (3D) imaging technologies using Artificial Intelligence (AI) and technologies used in NASA’s space telescopes. Their newly patented technology combines the power of illumination, fiber-optic bundles, and an electrically tunable liquid imaging lens to capture precise snapshots of lesions within a fraction of a second.

At the heart of Pensievision’s invention lies a compact yet powerful system. Fiber-optic bundles serve as conduits for emitted illumination light. These bundles, bendable and versatile, transmit light to an imaging camera situated at the proximal end. What sets this system apart is the electrically tunable liquid imaging lens, a marvel encompassing at least two transparent liquids within a flexible substrate.

Encased within an inflatable plastic balloon, the entire ensemble, including the electrically tunable lens, illumination component, and imaging camera, creates a protective cocoon. This enclosure is not just a physical shield; it also facilitates the manipulation of air pressure for size adjustments, ensuring adaptability to various imaging scenarios.

The core innovation lies in the driver accompanying the electrically tunable liquid imaging lens. This driver, configured for precise control, manipulates the lens’s effective focus. The result is a rapid succession of images captured at different focus settings, culminating in a single, sharp, all-focus image—a true technological feat in the world of medical imaging.

Pensievision’s system isn’t confined to a singular wavelength. Whether it’s infrared, ultraviolet, or visible light, the system accommodates a range of wavelengths to meet diverse imaging needs. The tunable liquid imaging lens, with diameters ranging from less than two millimeters to twenty millimeters, ensures versatility across various medical applications.

From imaging external lesions on the skin to capturing three-dimensional snapshots of tumors in confined spaces like the ear canal or arterial canal, Pensievision’s invention is a versatile tool in the fight against cancer. It’s not just about detection; the system offers detailed depth information, allowing for a comprehensive understanding of lesions.

The software accompanying this innovative system leverages a Maximum-Local-Derivative (MLD) algorithm, a tried-and-true method for extracting sharpness information. This software plays a crucial role in rendering and analyzing the images, ensuring that the data collected translates into meaningful insights for medical professionals.

In a world where early detection is paramount, Pensievision’s system emerges as a beacon of hope—a technological marvel that promises to revolutionize the way we perceive and analyze human lesions. The potential applications, from skin cancer to cervical cancer, open new frontiers in medical imaging, paving the way for enhanced diagnosis and improved patient outcomes.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts